Ureteral stent duration and the risk of BK polyomavirus viremia or bacteriuria after kidney transplantation

被引:28
|
作者
Wingate, Jonathan T. [1 ]
Brandenberger, Jared [2 ]
Weiss, Andrew [3 ]
Scovel, Lauren G. [2 ]
Kuhr, Christian S. [2 ]
机构
[1] Madigan Army Med Ctr, Dept Urol, Tacoma, WA 98431 USA
[2] Virginia Mason Med Ctr, Dept Urol & Renal Transplantat, Seattle, WA 98101 USA
[3] Virginia Mason Med Ctr, Dept Nephrol & Renal Transplantat, Seattle, WA 98101 USA
关键词
bacteriuria; BK nephropathy; BK viremia; ureteral stent; URINARY-TRACT-INFECTION; SINGLE-CENTER EXPERIENCE; UROLOGICAL COMPLICATIONS; RENAL-TRANSPLANTATION; NEPHROPATHY; IMPACT; RECIPIENTS; VIRUS;
D O I
10.1111/tid.12644
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ObjectivesUreteral stents are used in kidney transplantation (KTX) to decrease post-operative complications, but they are associated with BK polyomavirus viremia (BKV). Our primary outcome was to determine the association between ureteral stent duration and BKV. Secondary outcome measures were the association between bacteriuria and stent duration or use of ureteral stent strings. MethodsBetween January 2010 and January 2015, 403 patients underwent KTX at the Virginia Mason Medical Center and met inclusion criteria. Stent duration was classified as short (<3weeks) or long (>3weeks). Multivariate logistic regression models were created to assess for factors associated with BKV. The covariates in the BKV model were chosen a priori based on stent duration and risk factors previously described in the literature. ResultsUreteral stents were placed in 304 (75.4%) transplants. Stent strings were left attached in 166 (54.6%) patients. On multivariate analyses, long stent duration was significantly associated with increased risk of BKV compared with no stent (odds ratio [OR] 1.92, P=.044, 95% confidence interval [CI] 1.04-3.74). Short stent duration was not associated with BKV. Sixty-two (15.4%) patients had bacteriuria. Bacteriuria was associated with female gender (OR 2.77, P<.001, 95% CI 1.58-4.95), and there was a dose-dependent effect with stent duration compared with no stentshort duration (OR 2.46, P=.049, 95% CI 1.05-6.49) and long duration (OR 3.58, P=.004, 95% CI 1.58-9.25). Stent strings were not associated with either complication. ConclusionsThe association between ureteral stents and BKV may be dose dependent.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation
    Thurid Ahlenstiel-Grunow
    Lars Pape
    Pediatric Nephrology, 2020, 35 : 625 - 631
  • [32] Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation
    Ahlenstiel-Grunow, Thurid
    Pape, Lars
    PEDIATRIC NEPHROLOGY, 2020, 35 (04) : 625 - 631
  • [33] Risk factors and outcome of BK polyomavirus infection in pediatric kidney transplantation
    Lin, Fang
    Zhang, Zhiqing
    Wang, Chunyan
    Liu, Feng
    Chen, Rui
    Chen, Jing
    Fang, Xiaoyan
    Sun, Yubo
    Zhai, Yihui
    Xu, Hong
    Shen, Qian
    PEDIATRIC NEPHROLOGY, 2024, 39 (12) : 3559 - 3567
  • [34] T-cell immunity to polyomavirus BK after kidney transplantation
    Comoli, P.
    Azzi, A.
    Ginevri, F.
    JOURNAL OF NEUROVIROLOGY, 2005, 14 : 32 - 32
  • [35] Source and Relevance of the BK Polyomavirus Genotype for Infection After Kidney Transplantation
    Wunderink, H. F.
    de Brouwer, C. S.
    Gard, L.
    de Fijter, J. W.
    Kroes, A. C. M.
    Rotmans, J. I.
    Feltkamp, M. C. W.
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (03):
  • [36] URETERAL STENT MAY NOT BE ASSOCIATED WITH THE DEVELOPMENT OF SIGNIFICANT BK VIRURIA AND/OR VIREMIA
    Roman, Marcos A. Hernandez
    Narayanan, Mohanram
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (05) : A56 - A56
  • [37] Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy
    Reischig, Tomas
    Kacer, Martin
    Hes, Ondrej
    Machova, Jana
    Nemcova, Jana
    Lysak, Daniel
    Jindra, Pavel
    Pivovarcikova, Kristyna
    Kormunda, Stanislav
    Bouda, Mirko
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (09) : 2457 - 2467
  • [38] HLA-Antigens as a Risk Factor in Polyomavirus BK Viremia
    Randhawa, P.
    Ninomiya, T.
    Masutani, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 431 - 431
  • [39] CYTOMEGALOVIRUS PREVENTION STRATEGIES AND THE RISK OF BK POLYOMAVIRUS VIREMIA AND NEPHROPATHY
    Reischig, Tomas
    Kacer, Martin
    Hes, Ondrej
    Machova, Jana
    Nemcova, Jana
    Lysak, Daniel
    Kielberger, Lukas
    Benesova, Lenka
    TRANSPLANT INTERNATIONAL, 2019, 32 : 333 - 333
  • [40] Management of BK Viremia and Nephropathy in Pancreas After Kidney Transplantation and Pancreas Transplantation Alone
    Agarwal, Avinash
    Kane, Bartholemew J.
    Brayman, Kenneth L.
    TRANSPLANTATION, 2013, 96 (06) : S31 - S31